Abeona Therapeutics® to Host Second Quarter 2026 Financial Results Conference Call on August 13, 2026

Rhea-AI Summary

Abeona Therapeutics (Nasdaq: ABEO) will host a conference call on Thursday, August 13, 2026 at 8:30 a.m. ET to discuss its second quarter 2026 financial results and provide a corporate update. Results will be released in a press release before the call, with live access via phone and webcast, plus a 30-day archived replay on the company’s investor website.

Market Context

0.24% followed the comparable prior earnings-date notice, providing historical context rather than a...

Analysis

0.24% followed the comparable prior earnings-date notice, providing historical context rather than a result comparison. This announcement sets timing only; the platform also records net selling and high short positioning as risks to monitor.

Key Figures

Results period: Q2 2026 Conference call date: August 13, 2026 Conference call time: 8:30 a.m. ET +1 more

4 metrics

Results period Q2 2026 Financial results to be discussed on the conference call

Conference call date August 13, 2026 Scheduled financial results conference call

Conference call time 8:30 a.m. ET Scheduled call start time

Replay availability 30 days Archived webcast availability following the call

Previous Conferences,earnings date Reports

1 past event · Latest: Nov 07 (Neutral)

Same Type Pattern 1 events

Date	Event	Sentiment	24h Move	Catalyst
Nov 07	earnings date notice	Neutral	+0.2%	Scheduled third-quarter 2025 results call and investor conference participation

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

The tag-matched prior scheduling announcement was followed by a 0.24% gain; no contrary tag-matched event was provided.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

CLEVELAND, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that the Company will host a conference call on Thursday, August 13, 2026 at 8:30 a.m. ET to discuss its financial results for the second quarter of 2026 and provide a corporate update. Abeona will announce its financial results for this period in a press release to be issued prior to the call.

To access the live conference call, please dial 888-506-0062 (U.S. toll-free) or 973-528-0011 (international) and enter Entry Code: 245916 approximately five minutes prior to the start of the call.

A live, listen-only webcast and archived replay of the call can be accessed within the Investors & Media section of Abeona’s website at https://investors.abeonatherapeutics.com/events. The archived webcast replay will be available for 30 days following the conclusion of the call.

About Abeona Therapeutics^®
Abeona Therapeutics Inc. is a commercial-stage biopharmaceutical company developing cell and gene therapies for serious diseases. Abeona’s ZEVASKYN^® (prademagene zamikeracel) is the first and only autologous cell-based gene therapy for the treatment of wounds in adult and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The Company’s fully integrated cell and gene therapy cGMP manufacturing facility in Cleveland, Ohio, serves as the manufacturing site for ZEVASKYN commercial production. The Company’s development portfolio features ABO-701 (PSMA-SIR-T™), a potentially first-in-class engineered T-cell therapy targeting PSMA, engineered to overcome the core failures of cell therapies in solid tumors. For more information, visit www.abeonatherapeutics.com.

ZEVASKYN^®, Abeona Assist^®, Abeona Therapeutics^®, and their related logos are trademarks of Abeona Therapeutics Inc.

Contacts:
Investor and Media:
Greg Gin
VP, Investor Relations and Corporate Communications
Abeona Therapeutics
ir@abeonatherapeutics.com

Investor:
Lee M. Stern
Meru Advisors
lstern@meruadvisors.com

FAQ

When is Abeona Therapeutics' (ABEO) Q2 2026 earnings conference call?

Abeona Therapeutics will hold its Q2 2026 earnings conference call on Thursday, August 13, 2026 at 8:30 a.m. ET. According to Abeona Therapeutics, the call will cover financial results and provide a corporate update for investors.

How can investors access the Abeona Therapeutics (ABEO) Q2 2026 earnings call?

Investors can join the Abeona Therapeutics Q2 2026 call by dialing 888-506-0062 (U.S.) or 973-528-0011 (international) with Entry Code 245916. According to Abeona Therapeutics, participants should dial in about five minutes before the scheduled start.

Will Abeona Therapeutics (ABEO) provide a webcast replay of the August 13, 2026 call?

Yes, Abeona Therapeutics will offer a live, listen-only webcast and an archived replay of the August 13, 2026 call. According to Abeona Therapeutics, the replay will be available for 30 days in the Investors & Media section of its website.

Where can I find the Abeona Therapeutics (ABEO) Q2 2026 earnings webcast?

The Q2 2026 earnings webcast for Abeona Therapeutics will be available in the Investors & Media section of its website. According to Abeona Therapeutics, both the live webcast and 30-day archived replay can be accessed via its events page.

When will Abeona Therapeutics (ABEO) release its Q2 2026 financial results?

Abeona Therapeutics plans to release its Q2 2026 financial results in a press release issued prior to the August 13, 2026 conference call. According to Abeona Therapeutics, the call will then discuss these results and provide a corporate update.